Today: 9 April 2026
Subscribe
Browse Category

NYSE:GNRC 6 July 2025 - 18 December 2025

Energy Storage Stocks Surge at Midday as Grid Scarcity, Texas Battery Buildout, and Analyst Upgrades Refocus Wall Street

Energy Storage Stocks Surge at Midday as Grid Scarcity, Texas Battery Buildout, and Analyst Upgrades Refocus Wall Street

Energy storage stocks jumped at midday, with Sunrun up 7.7%, SES AI 7.4%, and Enphase 5.3%. Tesla and Fluence each rose 4.4%. Generac fell 3.5%. PJM’s latest capacity auction hit a record price cap, missing its reserve margin target by over 6,600 MW, as data center demand surged.
18 December 2025
·············
Smart Homes Just Got Smarter: New Gadgets, Big Trends & Surprising Challenges in Summer 2025

Smart Homes Just Got Smarter: New Gadgets, Big Trends & Surprising Challenges in Summer 2025

Generac launched the ecobee by Generac Smart Thermostat Enhanced in June 2025, promising up to 26% heating and cooling savings and integration with its generators and solar batteries. Arlo introduced Advanced Audio Detection for Arlo Secure Plus, while Yale released the Assure Lock 2 Touch with fingerprint unlocking. Amazon began rolling out Alexa Plus, and Google integrated Google Home into over 40 million devices as Matter controllers.
6 July 2025
··········

Stock Market Today

  • AbbVie's Humira Launch on TrumpRx with 86% Discount Sparks Valuation Questions
    April 9, 2026, 9:02 AM EDT. AbbVie (NYSE:ABBV) has introduced Humira on the TrumpRx platform at an 86% discount under a White House pricing deal aiming to reduce patient costs and widen drug access. This marks a significant US pricing strategy shift post exclusivity for Humira, a key immunology therapy driving substantial revenue. The stock trades near $206.69, about 20% below analyst targets and 43.8% under fair value estimates. The deep discount could alter patient volume, payer ties, and pricing benchmarks in government-linked drug programs. AbbVie's revenue exposure of $61.2 billion and a high price-to-earnings ratio of 87.3 place focus on potential impacts to cash flow and dividends amid its debt load. Investors should monitor reactions from payers, competitors, and capital markets to this pricing shift that could redefine AbbVie's US market dynamics.

Latest article

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

9 April 2026
Brent crude rebounded 3% Thursday despite a U.S.-Iran ceasefire, with the Strait of Hormuz still nearly shut and only one oil-products tanker passing in 24 hours. U.S. gasoline averaged $4.166 a gallon on April 9, and AAA said prices could drop slowly. North Sea Forties crude hit a record $146.43 a barrel. The U.S. EIA expects Hormuz flows may take months to recover.
CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

9 April 2026
CoreWeave said Meta Platforms committed about $21 billion for AI cloud capacity through December 2032. Shares rose 4.3% to $88.90 in premarket trading after the announcement. The deal follows an $8.5 billion loan facility and a $1.25 billion senior notes offering. CoreWeave reported $5.13 billion in 2025 revenue and ended December with a $66.8 billion backlog.
NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

9 April 2026
TrendForce said April 8 that Nvidia’s Rubin AI chip shipments may be delayed by HBM4 memory qualification and cooling demands, shifting over 70% of 2026 high-end GPU volume to the current Blackwell line. Rubin’s projected share dropped to 22%. Samsung began shipping HBM4 to Nvidia in February, but SK Hynix and Micron face qualification delays. Broadcom signed a long-term deal to develop Google’s TPUs through 2031.
Go toTop